These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 7693979)

  • 21. Erectile dysfunction: intracavernous treatment.
    Ledda A
    Curr Med Res Opin; 2000; 16 Suppl 1():s59-62. PubMed ID: 11329824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive history of injection therapy for erectile dysfunction, 1982-2023.
    Porst H; Lewis R; Virag R; Goldstein I
    Sex Med Rev; 2024 Jun; 12(3):419-433. PubMed ID: 38644056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in self-injection therapy for erectile dysfunction.
    Gingell JC
    Br J Urol; 1998 Apr; 81(4):599-603. PubMed ID: 9598634
    [No Abstract]   [Full Text] [Related]  

  • 24. Intracavernous pharmacotherapy for erectile dysfunction.
    Bella AJ; Brock GB
    Endocrine; 2004; 23(2-3):149-55. PubMed ID: 15146094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can self-injection therapy cure impotence?
    Sharlip ID
    Adv Exp Med Biol; 1997; 433():83-6. PubMed ID: 9561109
    [No Abstract]   [Full Text] [Related]  

  • 26. Intracavernous pharmacotherapy.
    Truss MC; Becker AJ; Schultheiss D; Jonas U
    World J Urol; 1997; 15(1):71-7. PubMed ID: 9066098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
    Montorsi F; Guazzoni G; Bergamaschi F; Orlandini A; Da Pozzo L; Barbieri L; Rigatti P
    J Urol; 1993 Dec; 150(6):1829-32. PubMed ID: 7693979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 32. [Endocavernous drug infusions revisited].
    Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.